Oscar-Werner Reif studied chemistry and molecular biology at the Leibniz University of Hanover and Vanderbilt University, USA, and received his doctorate in the field of technical chemistry. Since 1995, he has been working at Sartorius, initially in various managerial R&D functions in Germany, USA and Japan, and from 2005 onwards as R&D Director of the Biotechnology Division. In 2009, Reif was nominated to the Board of Directors of the French Sartorius subgroup Sartorius Stedim Biotech S.A.. In 2011, he was appointed honorary professor at Leibniz Universität Hanover. From 2011 to 2020, he was responsible for research and development of the entire Group and was a member of the Group Executive Committee, the company’s central management body. Since 2020, Oscar-Werner Reif has been the CTO of Sartorius AG and heads the Corporate Research. In addition to several commitments in professional associations Dr. Reif is a member of various supervisory boards as well as member of the board of DECHEMA and President of the German Technion Society (Deutschen Technion Gesellschaft).